16 February 2021

Press release

PolyPeptide Group today announced the appointment of Dr. Raymond De Vré as its new Chief Executive Officer. He will succeed Jane Salik who has decided to […]
9 February 2021

Congratulations Novavax!

PolyPeptide congratulates all at Novavax and its supply chain partners on the news that NVX-CoV2373, its protein-based COVID-19 vaccine candidate, met the primary endpoint, with a vaccine […]
28 January 2021

PolyPeptide News Flash, #1, 2021

PolyPeptide Group maintained a strong and healthy pipeline that has gained a significant growth in 2020. This growth in Pipeline Projects reflects the growth in peptide […]
17 September 2020
SPPS 600L reactor

PolyPeptide News Flash, #3, 2020

As a Global Leader in Peptide Manufacturing and Development, the PolyPeptide Group has been actively engaged on projects with clients who are developing peptide-based therapies and […]
4 June 2020
Press Release

Press Release: PolyPeptide Group Selected by Novavax to Manufacture Critical Intermediates of Matrix-M™ Adjuvant for its COVID-19 Vaccine

The PolyPeptide Group, a global Contract Development and Manufacturing Organization (CDMO) for Peptide, Peptidomimetic and other Drug Substances, has announced that it has partnered with Novavax […]
12 May 2020

PolyPeptide News Flash, #2, 2020

While the COVID-19 crisis continues, the PolyPeptide Group is actively engaged in helping find treatments and vaccines for COVID-19. See report on promising therapies in our […]
23 April 2020
Letter covid19

Information Letter on COVID-19

Download letter PDF here   Dear Valued Customer, While the COVID-19 crisis continues, I want to assure you that the PolyPeptide Group remains ready to support […]
24 February 2020
MVA Medicona Valley Alliance

New member of the Medicon Valley Alliance

We are happy to inform that the PolyPeptide Group is from now a member of the Medicon Valley Alliance (MVA). It is a non-profit membership organization, […]
COVID-19 Outbreak Information –